Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Ross

Showing results (231-240 of 345) with videos related to

Pageof 35
Sort By:
Iscience|April 28, 2022
Sex disparities in influenza: A multiscale network analysisChang Wang, Lauren P Lashua, Chalise E Carter, et al.
Mathematical Biosciences|March 10, 2011
An agent-based model of inflammation and fibrosis following particulate exposure in the lungBryan N Brown, Ian M Price, Franklin R Toapanta, et al.
Science Translational Medicine|May 31, 2013
Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenzaMaria P Limberis, Virginie S Adam, Gary Wong, et al.
Vaccine|October 7, 2014
H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccineSurender Khurana, Elizabeth M Coyle, Swati Verma, et al.
Vaccine|April 3, 2023
Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease virusesMiria F Criado, Aemro Kassa, Kateri Bertran, et al.
Journal of Virology|August 14, 2015
Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as AdjuvantVladimir Beljanski, Cindy Chiang, Greg A Kirchenbaum, et al.
Human Vaccines & Immunotherapeutics|June 15, 2022
Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune miceLeonard Moise, Lauren M Meyers, Hyesun Jang, et al.
Vaccine|October 25, 2003
Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutininIzumi Watanabe, Ted M Ross, Shin-ichi Tamura, et al.
Molecular Pharmaceutics|August 21, 2023
Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-StabilityDylan A Hendy, Liubov M Lifshits, Cole J Batty, et al.
Human Vaccines & Immunotherapeutics|July 11, 2019
Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B virusesMichael A Carlock, John G Ingram, Emily F Clutter, et al.
Pageof 35

Showing results (231-240 of 345) with videos related to

Sort By:
Pageof 35
Iscience|April 28, 2022
Sex disparities in influenza: A multiscale network analysisChang Wang, Lauren P Lashua, Chalise E Carter, et al.
Mathematical Biosciences|March 10, 2011
An agent-based model of inflammation and fibrosis following particulate exposure in the lungBryan N Brown, Ian M Price, Franklin R Toapanta, et al.
Science Translational Medicine|May 31, 2013
Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenzaMaria P Limberis, Virginie S Adam, Gary Wong, et al.
Vaccine|October 7, 2014
H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influenza vaccineSurender Khurana, Elizabeth M Coyle, Swati Verma, et al.
Vaccine|April 3, 2023
Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease virusesMiria F Criado, Aemro Kassa, Kateri Bertran, et al.
Journal of Virology|August 14, 2015
Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as AdjuvantVladimir Beljanski, Cindy Chiang, Greg A Kirchenbaum, et al.
Human Vaccines & Immunotherapeutics|June 15, 2022
Novel H7N9 influenza immunogen design enhances mobilization of seasonal influenza T cell memory in H3N2 pre-immune miceLeonard Moise, Lauren M Meyers, Hyesun Jang, et al.
Vaccine|October 25, 2003
Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutininIzumi Watanabe, Ted M Ross, Shin-ichi Tamura, et al.
Molecular Pharmaceutics|August 21, 2023
Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-StabilityDylan A Hendy, Liubov M Lifshits, Cole J Batty, et al.
Human Vaccines & Immunotherapeutics|July 11, 2019
Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B virusesMichael A Carlock, John G Ingram, Emily F Clutter, et al.
Pageof 35